If You Invested $1,000 in Trulieve Cannabis in 2018, This Is How Much You Would Have Today
A lot of the air has been let out of the marijuana market's balloon since the heady, early days of the Canadian green rush. The legalization of cannabis in Canada failed to supercharge growth in the way that was expected, and the patchwork, state-by-state efforts in the U.S. still leave pot producers caught up in a limbo of regulation and taxation that undermines their potential.
Yet one marijuana company still rises to the top despite the proliferation of competitors, and Trulieve Cannabis (OTC: TCNNF) remains one of the best-performing pot stocks on the market, even after seeing its own valuation cut by a third from the all-time high hit in March.
An investor who put $1,000 into Trulieve's reverse merger in 2018 would be doing quite well today, especially in comparison with other pot stocks available at the time. Let's see why the vertically integrated "seed to sale" medical marijuana company was such a good investment, and if it remains so today.
Source Fool.com